Single-Use Bioprocessing Consumables Market Size, Share And Trend Analysis Report By Region And Segmentation Forecasts

Market Outlook

The global single-use bioprocessing consumables market, valued at USD 8.1 billion in 2025, is projected to reach USD 8.9 billion in 2026 and USD 21.4 billion by 2035, representing a CAGR of 10.2% during the forecast period from 2026 to 2035.

To learn more about this report, request a free sample copy

Market Report: Key Takeaways

Market Size and Trends

• By workflow, upstream currently represents the leading segment in the single-use bioprocessing consumables market.
• By type of modality, monoclonal antibodies hold the largest share, accounting for close to 50% of the current market.
• By type of application, cell culture currently accounts for the largest share of the market.
• By end user, pharmaceutical and biopharmaceutical companies represent the leading segment in the single-use bioprocessing consumables market.
• By geographical regions, Europe accounts for the largest share, representing approximately 35% of the current market.

Key Market Statistics

• Market Size in 2026: USD 8.9 billion
• Estimated Market Size in 2035: USD 21.4 billion
• CAGR (2026 to 2035): 10.2%
• Europe: Largest market in 2026
• Fastest-Growing Regional Market: Asia-Pacific

Market Introduction

Biopharmaceutical manufacturing increasingly requires production systems that can accommodate multiple products, changing batch volumes and shorter development timelines. Single-use bioprocessing consumables, including bags, tubing, connectors, filters, sensors and sampling assemblies, support this flexibility by providing product-contact pathways that reduce cleaning requirements, lower cross-contamination risk and accelerate equipment changeovers.

Adoption is expanding as pharmaceutical companies, biotechnology firms and contract manufacturers increase production of monoclonal antibodies, vaccines, recombinant proteins and advanced therapies. Because many consumables are replaced after each manufacturing cycle, they generate recurring demand across upstream processing, downstream purification, media and buffer preparation, fluid transfer, storage and final formulation.

Recent capacity expansions demonstrate the growing commercial importance of the category. In June 2025, Sartorius expanded its Aubagne facility in France, nearly doubling its cleanroom space to approximately 9,000 m² and increasing capacity for single-use bags used in cell culture and storage. In April 2025, Thermo Fisher Scientific introduced the 5 L DynaDrive™ single-use bioreactor, extending a standardized reactor and film platform across scales of 1–5,000 L. Although the bioreactor is equipment, expansion of a standardized platform can increase recurring demand for compatible bags, films and fluid-path assemblies.

The market is also expected to benefit from modular manufacturing facilities, expanding biologics pipelines and greater use of intensified and continuous bioprocesses. Suppliers are developing more integrated and scalable portfolios; for example, Qosina added more than 250 products during the first half of 2025, including tubing, manifolds, bag ports, valves and connectors for medical and bioprocessing applications. Continued improvements in material compatibility, supply-chain traceability and standardized connection technologies are expected to strengthen the role of single-use consumables in commercial biomanufacturing.

Leading Single-Use Bioprocessing Consumable Platforms and Applications

Abbreviations: YoE: Year of Establishment, HQ: Headquarters

Market Segmentation

Based on the research, the single-use bioprocessing consumables market is segmented by workflow, type of modality, type of application, end user and geographical regions.

• By Workflow: Upstream and Downstream
• By Type of Modality: Monoclonal Antibodies, Peptides, Vaccines, Cell and Gene Therapies, Biosimilars, Bi-/Multispecific Antibodies, Antibody-drug conjugates, mRNA, and Others
• By Type of Application: Cell Culture, Filtration, Purification, Storage and Transfer, Mixing, and Others
• By End User: Pharmaceutical and Biopharmaceutical Companies, CROs and CMOs, and Others
• By Geographical Regions: North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa

Single-Use Bioprocessing Consumables Market Key Insights

What are the Key Drivers for Single-Use Bioprocessing Consumables Market Growth?

• Expansion of Biologics and Advanced-Therapy Manufacturing: Increasing production of monoclonal antibodies, vaccines, antibody-drug conjugates, recombinant proteins and cell and gene therapies is supporting recurring demand for sterile bags, tubing, filters, connectors, sensors, and sampling assemblies. These products enable flexible manufacturing while reducing cross-contamination risk across fluid handling, filtration, sampling and storage operations.
• Lower Cleaning and Validation Requirements: Preassembled and pre-sterilized consumables reduce cleaning, sterilization and validation between batches. This can shorten turnaround time, lower utility use and equipment downtime, and improve manufacturing throughput. In 2025, Cytiva reported that single-use flow paths and prepacked columns can reduce downstream system setup time compared with conventional systems.

What are the Main Challenges for Market Growth?

• Extractables and Leachables Compliance: Polymeric bags, tubing, filters and connectors can release chemical compounds into process fluids, requiring manufacturers to assess potential effects on product quality and patient safety. Moreover, compliance requirements are becoming increasingly rigorous following the implementation of USP <665> in May 2026. This standard provides a risk-based approach for qualifying plastic components used in pharmaceutical manufacturing, thereby increasing testing, documentation and supplier qualification requirements.
• Risk of Bag Leaks and Assembly Failures: Bags and assemblies can be damaged through puncturing, tearing, incorrect installation or improper handling. A failure during processing can cause product loss, contamination investigations and manufacturing downtime. BioPhorum reports that the cost of an individual leak can range from thousands to several million dollars and highlights the absence of a universal standard for handling and deploying single-use systems.

Recent Developments in Single-Use Bioprocessing Consumables Market

• In July 2026, Repligen entered into a definitive agreement to acquire BioLife Solutions. The proposed transaction will add BioLife's biopreservation media and related consumable products used in cell and gene therapy manufacturing workflows to Repligen's portfolio, strengthening its presence in recurring, workflow-integrated bioprocessing consumables.
• In July 2026, CPC Biotech launched RevolveSD Series, a one-inch, single-use sterile disconnect for bioprocess tubing. The connector enables sterile disconnection in fewer steps than clamp- or sealer-based methods for high-flow biopharmaceutical manufacturing.
• In April 2026, Saint-Gobain Life Sciences and VERDOT entered a strategic collaboration to jointly develop and commercialize a next-generation PUPSIT solution for GMP-regulated biopharmaceutical manufacturers. The partnership combines VERDOT's downstream systems with Saint-Gobain's engineered single-use assemblies.

Industry Experts on Single-Use Bioprocessing Consumables Market

Driven by the increasing adoption of single-use technologies that offer greater manufacturing flexibility, reduced contamination risk, and lower cleaning and validation requirements, the single-use bioprocessing consumables market is poised for significant growth in the coming years.

Emphasizing this, Narayana Rao (Vice President, Avantor), stated that: "The shift to single-use products has allowed for benefits such as improved batch turnaround times, reduced risk of product cross-contamination, and greater sustainability with less water and steam being used than more traditional bioproduction methods. Single-use technologies are more flexible as well as quicker to set up at a lower cost than traditional stainless-steel equipment."

Discussions with multiple stakeholders in this domain influenced the opinions and insights presented in this study. The single-use bioprocessing consumables market report includes detailed transcripts of interviews conducted with the following individuals:

• Technical Director & Co-owner, Small Company, Netherlands
• R&D Staff Scientist and Engineer, Very Large Company, US

In addition, the market report includes transcripts of the following other third-party discussions:

• Managing Director and Co-Founder, Small Company, India
• Founder, Small Organization, US
• Vice President, Very Large Company, US
• Business Development Manager / Single-Use Fluid Transfer Specialist, Large Company, US
• Life Sciences Industry Marketing Manager, Very Large Company, US
• Product Line Manager, Mid-sized Company, Austria
• Technical Product Owner, Sterile Consumables, Mid-sized Company, Austria
• Market Manager, Mid-sized Company, US
• Process Consultant, Mid-sized Company, Austria
• Product Management Director, Large Company, Germany

Market Share Insights

Which Type of Modality Accounts for the Largest Share of the Single-Use Bioprocessing Consumables Market?

In 2026, the monoclonal antibodies segment accounts for the largest share, representing close to 50% of the single-use bioprocessing consumables market. Monoclonal antibodies are commonly produced using standardized mammalian cell-culture processes, particularly using CHO cell systems, which are compatible with scalable single-use bioreactors and associated fluid-management systems.

Each production batch requires disposable bioreactor bags, media- and buffer-preparation bags, tubing assemblies, sterile connectors, filters, sampling systems and storage containers, generating substantial recurring demand. In April 2025, AGC Biologics announced plans to install two 5,000-litre single-use bioreactors at its new Yokohama facility in Japan to support large-scale mammalian and monoclonal antibody manufacturing.

The mRNA segment is expected to register the highest CAGR, at 12.6%, during 2026–2035. Growth is supported by expansion of the mRNA pipeline beyond COVID-19 vaccines into personalized cancer vaccines, respiratory vaccines, rare-disease treatments and other therapeutic applications, increasing the number of clinical and commercial manufacturing campaigns.

Which Type of Application Accounts for the Largest Share of the Single-Use Bioprocessing Consumables Market?

The cell culture segment accounts for the largest share of the market in 2026 and is also expected to register the highest CAGR during the forecast period. Cell culture is a consumable-intensive upstream operation used in the production of multiple biologic modalities.

The adoption of single-use bioreactors in cell-culture operations from process development through commercial manufacturing scales has increased the volume and value of consumables used per batch. Thermo Fisher Scientific's DynaDrive platform supports cell-culture operations across capacities ranging from 5–5,000 litres, while Sartorius' Flexsafe STR systems integrate disposable bags, sensors, tubing and sterile connectors within a single cell-culture assembly.

Regional Analysis: Which Regions are Showing the Fastest Growth in Single-Use Bioprocessing Consumables Industry?

Europe Dominates the Market by Securing Highest Share

Europe is projected to account for the largest share, approximately 35%, of the single-use bioprocessing consumables market in 2026. This position reflects the region's concentration of biologics manufacturers, vaccine developers and CDMOs across Germany, Switzerland, Denmark, France, Ireland and Belgium. Their multiproduct facilities generate recurring demand for bags, tubing, filters, connectors and fluid-transfer assemblies.

Asia-Pacific Is the Fastest-Growing Region

Asia-Pacific is expected to be the fastest-growing regional market through 2035. Growth is supported by expansion of biologics, biosimilars, vaccines and advanced-therapy manufacturing capacity across China, India, Japan, South Korea and Singapore. For instance, Singapore reports more than 60 biopharmaceutical manufacturing plants, including facilities producing biologics, cell therapies and antibody-drug conjugates.

Key Players in the Single-Use Bioprocessing Consumables Market

The report profiles Cytiva, Entegris, Meissner, Merck, Saint-Gobain, Sartorius, Thermo Fisher Scientific, and Watson-Marlow Fluid Technology Solutions.

Report Deliverables and Customization

Alongside the core market report, purchasers receive complimentary Excel data packs covering the single-use bioprocessing consumables market landscape, company competitiveness analysis, recent developments, and market sizing and opportunity analysis. A complimentary PowerPoint presentation summarizing the full report is also included, and 15% free customization scope is available on request.

Report Authorship

This report was authored by Tanvi Chadha, a member of Roots Analysis' healthcare and pharmaceutical research practice. Her work focuses on competitive intelligence, company benchmarking and market forecasting.

Independence and Non-Affiliation

Roots Analysis is an independent secondary and primary market research publisher. This report is not affiliated with, endorsed by, or produced on behalf of any company named or profiled within it, including all key players and industry expert interviewees referenced above.

Roots Analysis' findings draw on a combination of secondary research and primary interviews with industry experts, of the kind referenced above, to validate market sizing, segment shares, and forecast assumptions independently of any single company's disclosures.